BioNTech SE (BNTX) Long-Term Investments (2018 - 2023)

BioNTech SE (BNTX) has 5 years of Long-Term Investments data on file, last reported at $185.0 million in Q1 2023.

• For the quarter ending Q1 2023, Long-Term Investments changed N/A year-over-year to $185.0 million; the trailing twelve-month figure through Mar 2023 stood at $185.0 million (changed N/A YoY), and the FY2022 full-year result was $179.8 million, up 613.18% from the prior year.
• Long-Term Investments rose to $185.0 million in Q1 2023, from $179.8 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $185.0 million in Q1 2023 to a low of $24.4 million in Q4 2021.
• A 4-year average of $112.4 million and a median of $120.0 million in 2019 frame the typical range for Long-Term Investments.
• Peak annual rise in Long-Term Investments reached 637.76% in 2022, while the deepest fall reached 637.76% in 2022.
• Tracing BNTX's Long-Term Investments over 4 years: stood at $60.3 million in 2019, then sank by 59.61% to $24.4 million in 2021, then jumped by 637.76% to $179.8 million in 2022, then grew by 2.94% to $185.0 million in 2023.
• Business Quant data shows BNTX's Long-Term Investments at $185.0 million in Q1 2023, $179.8 million in Q4 2022, and $24.4 million in Q4 2021.